Hyaluronic Acid Market Size Worth Around USD 11 bn by 2026

World News: . []

LOS ANGELES, June 12, 2019 (GLOBE NEWSWIRE) -- The global size is expected to reach 11.07 billion by the end of year 2026. The market is estimated to grow at a CAGR of 6.6% over the forecast period 2019 to 2026.

Hyaluronic acid, likewise called hyaluronan, is an anionic, nonsulfated glycosaminoglycan conveyed broadly all through connective, epithelial, and neural tissues. Hyaluronic acid is likewise utilized as a lip filler in a plastic medical procedure. Some people use hyaluronic acid for their skin for recuperating wounds, skin ulcers, cosmetics, and as a lotion. There is likewise a great deal of enthusiasm for utilizing hyaluronic acid to avert the impacts of maturing.

The worldwide hyaluronic acid market is seeing development on the back of rising interest from beauty care products and therapeutic applications. Additionally, the developing rate of ulcers, osteoarthritis and geriatric populace is another central point crediting towards market development. In any case, another savvy treatment present in the market and hypersensitive response related to it can limit the market development. Headway in innovation towards better wellbeing administrations is anticipated to fuel the market interest for hyaluronic acid.

The global hyaluronic acid market is segmented into application, and region. On the basis of application, the global market is segmented into dermal fillers, osteoarthritis, ophthalmic, and vesicoureteral reflux. Further, osteoarthritis segment is sub segmented into single injection, three injection, and five injection. On the basis of geography, the global market is segment into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

Single-infusion cycle is foreseen to be the quickest developing segment because of high inclination for short treatment term and snappy outcomes. Organizations are acquainting more current innovation and items with satisfying this interest. In 2016, Genzyme Corporation got the FDA endorsement for its single-infusion treatment routine, Synvisc-One. The item contains high-sub-atomic weight polymers of hyaluronic acid that go about as grease and decrease the torment. The ophthalmic segment is expected to witness the quickest CAGR over the estimate time frame.

Key elements adding to the segment development incorporate expanding frequencies of sicknesses, for example, waterfalls, glaucoma, age-related macular degeneration, and dry eyes. This gives a few chances to the development of ophthalmology-related uses of hyaluronic acid items. Waterfall and focal point systems are one of the top outpatient surgeries in the U.S.

North America market is expected to represent the most extreme income offer of over 40% by the end of 2026. The U.S. is the most significant market and records for the larger part offer of the North America territorial market. High wellbeing mindfulness and brisk selection of new advancements and treatment strategies are expected to drive the territorial market further.

The Asia Pacific market is expected to develop as the quickest developing local market over the gauge time frame. Japan is one of the most astounding supporters of the area's income attributable to the expanding geriatric populace and bringing issues to light about style. Created markets like the US and Europe are bringing in the hyaluronic acid compound from Asia-Pacific nations, for example, China. The quickly maturing statistic profiles of the different nations in the Asia-Pacific district including Japan, Australia, and China have displayed an immense open door for the dietary supplement and beauty care products industry to create and increase expanding incomes in the hyaluronic acid market.

Key business systems including mergers and acquisitions and new item improvement are foreseen to increase the market elements over the estimate time frame. For example, in 2015, Valeant Pharmaceuticals gained Salix Pharmaceuticals Ltd. In 2013, the organization additionally procured Bausch + Lomb Holdings Inc., an eye care items organization. In addition, organizations, for example, Galderma, Actavis, and Rayner Surgical Group Ltd., have procured organizations to broaden their item portfolio.

Major companies contributing the global hyaluronic acid market are Anika Therapeutics, Inc., Allergan, Inc., Ferring Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Galderma S.A., Salix Pharmaceuticals, Sanofi (Genzyme), Seikagaku Corporation, Smith & Nephew Plc, and Zimmer Holdings, Inc.

More news and information about Acumen Research and Consulting

Published By:

Globe Newswire: 15:00 GMT Wednesday 12th June 2019

Published: .

Search for other references to "hyaluronic" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us